Robert Kamen

Insider Reports History

Entity
Individual
Location
C/O Jounce Therapeutics, Inc., 1030 Massachusetts Avenue, Boston, MA
Signature
/s/ Caroline Gammill, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Kamen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Jounce Therapeutics, Inc. Director Common Stock 0 $1.85 May 3, 2023 Direct
Jounce Therapeutics, Inc. Director Common Stock 0 $1.85 May 3, 2023 Indirect
Jounce Therapeutics, Inc. Director Stock Option (Right to Buy) 0 May 3, 2023 Direct

Insider Reports Filed by Robert Kamen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JNCE Jounce Therapeutics, Inc. May 3, 2023 8 $0 4 May 4, 2023 Director
JNCE Jounce Therapeutics, Inc. Jun 24, 2022 1 $0 4 Jun 28, 2022 Director
JNCE Jounce Therapeutics, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director